A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study

Radiotherapy and Oncology

Volumn 110, Issue 1, 2014, Pages 98-103

  Moon, Sung Ho ^a   Cho, Kwan Ho ^a   Chung, Eun Ji ^b   Lee, Chang Geol ^c   Lee, Kyu Chan ^d   Chai, Gyu Young ^e   Kang, Ki Mun ^e   Lee, Jong Young ^f   Chung, Woong Ki ^g   Park, Woo Yoon ^h   Kim, Jin Hee ⁱ  

^a National Cancer Center   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Gachon University   (South Korea)

^e Gyeongsang National University   (South Korea)

^f Wonju Severance Christian Hospital   (South Korea)

^g Chonnam National University Medical School   (South Korea)

^h Chungbuk National University Hospital   (South Korea)

ⁱ Dongsan Medical Center   (South Korea)

Author keywords

Fraction size; Glottic carcinoma; Hypofractionation; Radiotherapy

Indexed keywords

ADULT; AGED; BILE DUCT CARCINOMA; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; DISTANT METASTASIS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNX DISORDER; LARYNX SQUAMOUS CELL CARCINOMA; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN TOXICITY; TREATMENT PLANNING; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GLOTTIS; HEAD AND NECK NEOPLASMS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; GLOTTIS; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE;

EID: 84896094911     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.09.016     Document Type: Article

References (17)

1. K.M. Higgins, M.D. Shah, and M.J. Ogaick et al. Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy J Otolaryngol Head Neck Surg 38 2009 603 612
2. K. Saarilahti, M. Kajanti, and H. Lehtonen et al. Repopulation during radical radiotherapy for T1 glottic cancer Radiother Oncol 47 1998 155 159 (Pubitemid 28275925)
3. K. Skladowski, R. Tarnawski, and B. Maciejewski et al. Clinical radiobiology of glottic T1 squamous cell carcinoma Int J Radiat Oncol Biol Phys 43 1999 101 106 (Pubitemid 29065838)
4. Q.T. Le, K.K. Fu, and S. Kroll et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma Int J Radiat Oncol Biol Phys 39 1997 115 126 (Pubitemid 27396288)
5. E. Yu, G. Shenouda, and M.P. Beaudet et al. Impact of radiation therapy fraction size on local control of early glottic carcinoma Int J Radiat Oncol Biol Phys 37 1997 587 591 (Pubitemid 27175314)
6. W.M. Mendenhall, J.W. Werning, and R.W. Hinerman et al. Management of T1-T2 glottic carcinomas Cancer 100 2004 1786 1792 (Pubitemid 38529554)
7. N.J. Slevin, S. Vasanthan, and M. Dougal Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy Int J Radiat Oncol Biol Phys 25 1993 23 28 (Pubitemid 23029769)
8. K.W. Jung, Y.J. Won, and H.J. Kong et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010 Cancer Res Treat 45 2013 1 14
9. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
10. H. Yamazaki, K. Nishiyama, and E. Tanaka et al. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time Int J Radiat Oncol Biol Phys 64 2006 77 82 (Pubitemid 41831212)
11. W.M. Mendenhall, J.T. Parsons, and R.R. Million et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications Int J Radiat Oncol Biol Phys 15 1988 1267 1273 (Pubitemid 19015466)
12. D.A. Fein, W.R. Lee, and A.L. Hanlon et al. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys 34 1996 823 831 (Pubitemid 26089220)
13. W. Small Jr., B.B. Mittal, and W.N. Brand et al. Results of radiation therapy in early glottic carcinoma: multivariate analysis of prognostic and radiation therapy variables Radiology 183 1992 789 794
14. S.P. Reddy, R.L. Hong, and S. Nagda et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience Int J Radiat Oncol Biol Phys 69 2007 1389 1394 (Pubitemid 350116416)
15. C.C. Tong, K.H. Au, and R.K. Ngan et al. Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons Radiat Oncol 6 2011 53
16. E. Cellai, P. Frata, and S.M. Magrini et al. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I the case of T1N0 disease Int J Radiat Oncol Biol Phys 63 2005 1378 1386 (Pubitemid 41628032)
17. W.M. Mendenhall, R.J. Amdur, and C.G. Morris et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy J Clin Oncol 19 2001 4029 4036 (Pubitemid 32976689)